Stephen Hoge - 11 Feb 2026 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
President
Signature
/s/ James Dillon, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
11 Feb 2026
Net transactions value
-$99,180
Form type
4
Filing time
13 Feb 2026, 16:33:12 UTC
Previous filing
02 Dec 2025
Next filing
25 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoge Stephen President C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, as Attorney-in-Fact 13 Feb 2026 0001760669

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Award $0 +4,884 +0.34% $0.000000 1,459,789 11 Feb 2026 Direct F1
transaction MRNA Common Stock Tax liability $99,180 -2,362 -0.16% $41.99 1,457,427 11 Feb 2026 Direct F2
holding MRNA Common Stock 4,116 11 Feb 2026 By Valhalla, LLC
holding MRNA Common Stock 151,933 11 Feb 2026 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs").
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs.
F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.